Implantable medical device
AssigneeDepuy International Limited
InventorsYufu Li, Deborah Schachter, Raymond S. Shissias, Sandra Wechsler
Life of this patent
Estimating the term…
Abstract
An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug which is highly soluble in water, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.
Claims20
An implantable medical device comprising:
- an orthopedic device substrate having a surface;
- a coating on the surface of the substrate, wherein the coating consists essentially of a water soluble antibiotic drug, wherein the solubility of the drug, measured by making a saturated solution of the drug in deionised water at 25 C, is at least 40 g·l−1;
- and wherein the water soluble antibiotic drug is present on the surface of the substrate in a dosage of at least about 250 μg·cm−2;
- and,
- a protective layer which overlies the coating, the protective layer comprising a polymer having a weight average molecular weight of not more than 40,000 g/mol, wherein the polymer comprises polylactic acid, polyglycolic acid or a lactic acid/glycolic acid copolymer;
- wherein the thickness of the protective layer is not more than about 20 μm;
- wherein the device is configured to release at least 90% of the drug within 1 day;
- wherein the device is configured to contact bone;
- and,
- wherein the device is configured to control infection at an orthopedic surgical site.
An implantable medical device for controlling infection at an orthopedic surgical site and configured to contact bone comprising:
- an orthopedic device substrate having a metallic surface;
- a coating on the surface of the metallic substrate, wherein the coating consists essentially of gentamicin sulfate present on the surface of the metallic substrate in a dosage of at least about 400 μg·cm−2 to not more than about 2000 μg·cm−2;
- and,
- a protective layer having a thickness of less than 20 μm which overlies the coating, the protective layer comprising a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 20,000 g/mol, and a molar ratio of lactic acid to glycolic acid of about 50:50;
- wherein the device is configured to release at least 60% of the drug within 3 hours;
- wherein the device is configured to release at least 90% of the drug within 24 hours;
- wherein the device is configured to contact bone;
- and,
- wherein the device is configured to control infection at an orthopedic surgical site.
Dependencies are inferred from the claim text.